Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study.
Kenji TanabeShuichiro KobayashiYuya MaezawaKensaku IshiharaNaoki InoueKeita IzumiMotohiro FujiwaraMasahiro ToideTakanobu YamamotoSho UeharaSaori ArakiMasaharu InoueRyoji TakazawaNoboru NumaoYukihiro OhtsukaHajime TanakaSoichiro YoshidaYasuhisa FujiiPublished in: International journal of clinical oncology (2024)
The GRIm-score is an independent prognostic marker for survival outcomes in patients with platinum-refractory metastatic UC treated with pembrolizumab.